Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

41.23

-0.73 (-1.74%)

At close: Apr 30, 2025, 3:59 PM

41.82

1.43%

After-hours: Apr 30, 2025, 04:56 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-10.93M	-1.3K	-1.72M	-1.64M	-1.81M	-1.95M	-2.2M	-2.43M	-2.9M	-2.4M	-2.76M	-2.46M	-2.68M	-2.46M	-2.08M	-1.88M	-2.13M	-1.64M	-1.45M	-1.09M	-1.21M	-736.08K	-905.7K	-1.38M	-890.46K	-640.18K	-820.94K	-876.35K	-713.58K	-14.88M	-591.44K	-372.92K	-320.47	-193.11	-336.01	-336.01
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	278.61K	861.84M	334.39	328.66K	474.21K	474.14K	473.3K	476.21K	393.42K	390.74K	357.29K	499.81K	350.16K	392.06K	357.59K	368.23K	331.32K	283.71K	367.36K	338.5K	276.81K	242.96K	257.63K	233.78K	232.99K	93.24K	88.57K	114.53K	63.19K	43.93K	198.09K	n/a	n/a	n/a	n/a	n/a
Other Working Capital	2.96M	610.04K	49.87K	-31.62K	6.81K	36.67K	-3.05K	-60.84K	5.25K	4.49K	2.58K	21.73K	-42.09K	-11.24K	19K	-51.88K	41.86K	76.61K	-80.17K	-42.08K	-42.88K	9.27K	7.46K	-21.36K	-155.67K	-41.38K	-53.04K	-25.76K	-139.56K	1.7K	3.5K	7.57K	-5.73	29.88	-11.93	-11.93
Other Non-Cash Items	4.55M	-5.26B	680.14K	639.9K	687.21K	971.03K	845.02K	728.13K	-802.45K	-277.53	-734.99K	1.03M	9.55K	255.77K	60.14K	738.63K	-122.4K	-21.42	163.15	-331.11	-1	1.00	-99.13	167.85	87.66	-11.25	32.54	-21.27	-26.07	13.5M	84.72	53.86	-174.14	-16.19	90.50	90.50
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.1M	638.74K	-295.88K	-342.86K	-206.19K	-460.22K	-374.77K	-312.77K	1.2M	-139.57K	1.09M	-510.59K	298.52K	125.06K	316.46K	-422.27K	678.83K	55.19K	82.98K	-373.19K	261.35K	-120.14K	-91.67K	146.49K	-68.01K	-52.62K	-20.49K	-47.03K	-165.63K	136.55K	88.22K	61.43K	27.28	-3.13	-11.93	-11.93
Operating Cash Flow	-2M	-4.4B	-1.68M	-1.66M	-1.55M	-1.94M	-2.1M	-2.27M	-1.3M	-2.15M	-1.31M	-2.47M	-2.03M	-1.94M	-1.41M	-1.94M	-1.24M	-1.3M	-995.47K	-1.13M	-668.71K	-613.27K	-739.74K	-995.97K	-725.48K	-599.56K	-752.86K	-808.85K	-816.02K	-1.19M	-305.13K	-311.49K	-467.33	-212.43	-257.44	-257.44
Capital Expenditures	n/a	n/a	-2	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-14.34M	n/a	-2.42K	-983.31K	9.24K	-2.97M	-1.96M	-2.96M	-4.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	985.73K	n/a	n/a	2.96M	2.96M	4.92M	1.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-2.42	-983.31	2.97K	-13.05	2.95K	-983.44	-4.92K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-14.34M	985.73K	-2.42K	-983.31K	2.97M	-13.05K	2.95M	-983.44K	-4.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	20.74	-10	n/a	n/a	n/a	n/a	n/a	n/a	-10.67K	-29.66	-16.67	-7.77	-9.98	-24	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-66.95K	-16.53K	-9.92K	-10.74K	-5.32K	-8.21K	-16.61K	-16.83K	29.4K	-13.07K	-65.46K	-16.67K	-7.77K	-9.98K	-24K	-4.02K	-7.14K	-18.91K	32.88K	n/a	9.39M	-13.28K	-12.32K	-13.86K	-206.27K	n/a	n/a	n/a	1.00	4.83M	n/a	n/a	n/a	n/a	631.25	631.25
Financial Cash Flow	56.14M	-16.53K	-9.92K	3.18M	334.55K	246.7K	641.18K	804.8K	138.74K	-23.74K	-65.46K	-16.67K	-7.77K	-9.98K	-24K	10.92M	-7.14K	6.73M	946.4K	508.04K	9.39M	-13.28K	-12.32K	-13.86K	-206.27	n/a	n/a	n/a	10K	7.5M	1.04M	990K	n/a	n/a	631.25	631.25
Net Cash Flow	39.8M	-99.85	-1.69M	541.5K	1.75M	-1.7M	1.49M	-2.46M	-6.13M	-2.15M	-1.36M	-2.48M	-2.04M	-1.95M	-1.43M	8.99M	-1.25M	5.44M	-46.17K	-621.57K	8.72M	-635.29K	-751.24K	-1.01M	-725.49K	-600.38K	-754.43K	-808.85K	-806.02K	6.31M	729.91K	678.52K	-467.33	-212.43	373.81	373.81
Free Cash Flow	-2M	-1.07M	-1.68M	-1.66M	-1.55M	-1.94M	-2.1M	-2.27M	-1.3M	-2.15M	-1.31M	-2.47M	-2.03M	-1.94M	-1.41M	-1.94M	-1.24M	-1.3M	-995.47K	-1.13M	-668.71K	-613.27K	-739.74K	-995.97K	-725.48K	-599.56K	-752.86K	-808.85K	-816.02K	-1.19M	-305.13K	-311.49K	-467.33	-212.43	-257.44	-257.44